Oaktree Acquisition Corp. III Life SciencesOACC
What Oaktree Acquisition Corp. III Life Sciences does.
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Report as our initial business combination. To date, our efforts have been limited to organizational activities, activities related to our initial public offering and our search for an initial business combination. We have not selected any specific business combination target yet. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination.
While we may pursue an acquisition opportunity in any business, industry, sector, or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we intend to target North American, British or European companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors where our management has extensive investment experience.
Revenue and profit, by fiscal year.
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Net income | — | $7.3M |
More on OACC.
- Oaktree Acquisition Corp. III Life Sciences summary
- Oaktree Acquisition Corp. III Life Sciences financial statements
- Oaktree Acquisition Corp. III Life Sciences key metrics
- Oaktree Acquisition Corp. III Life Sciences health scores and style box
- Oaktree Acquisition Corp. III Life Sciences earnings
- Oaktree Acquisition Corp. III Life Sciences dividends
- Oaktree Acquisition Corp. III Life Sciences valuation
- Oaktree Acquisition Corp. III Life Sciences ownership and insiders
- Oaktree Acquisition Corp. III Life Sciences peers
Figures from Oaktree Acquisition Corp. III Life Sciences's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.